These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21209974)

  • 21. Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate: review of statistical analysis.
    Eastell R; Hannon RA; Garnero P; Campbell MJ; Delmas PD
    J Bone Miner Res; 2007 Nov; 22(11):1656-60. PubMed ID: 17931100
    [No Abstract]   [Full Text] [Related]  

  • 22. Once-a-week risedronate (actonel).
    Med Lett Drugs Ther; 2002 Oct; 44(1141):87-8. PubMed ID: 12381968
    [No Abstract]   [Full Text] [Related]  

  • 23. What is the optimal duration of bisphosphonate therapy?
    Ott SM
    Cleve Clin J Med; 2011 Sep; 78(9):619-30. PubMed ID: 21885695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of combination treatment for osteoporosis.
    Recker RR; Heaney RP
    J Clin Endocrinol Metab; 2001 May; 86(5):1888-9. PubMed ID: 11344178
    [No Abstract]   [Full Text] [Related]  

  • 25. [Application of anti-resorptive drugs for the treatment of osteoporosis].
    Takada J
    Nihon Rinsho; 2006 Feb; 64(2):385-91. PubMed ID: 16454196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recognition of women at risk for fracture and intervention with fast-acting therapies.
    Derman R
    Int J Fertil Womens Med; 2006; 51(4):183-90. PubMed ID: 17184104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP
    Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Osteoporosis therapy. Bisphosphonates compared].
    MMW Fortschr Med; 2003 Mar; 145(13):60. PubMed ID: 15101545
    [No Abstract]   [Full Text] [Related]  

  • 29. Risedronate-induced Hepatitis.
    Phillips MB
    Am J Med; 2007 Mar; 120(3):e1-2. PubMed ID: 17349419
    [No Abstract]   [Full Text] [Related]  

  • 30. Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: the risedronate and alendronate (REAL) cohort study.
    Silverman SL; Watts NB; Delmas PD; Lange JL; Lindsay R
    Osteoporos Int; 2007 Jan; 18(1):25-34. PubMed ID: 17106785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteonecrosis of the jawbones in 2 osteoporosis patients treated with nitrogen-containing bisphosphonates: osteonecrosis reduction replacing NBP with non-NBP (etidronate) and rationale.
    Yamaguchi K; Oizumi T; Funayama H; Kawamura H; Sugawara S; Endo Y
    J Oral Maxillofac Surg; 2010 Apr; 68(4):889-97. PubMed ID: 20056305
    [No Abstract]   [Full Text] [Related]  

  • 32. Changes in urinary NTX levels in patients with primary osteoporosis undergoing long-term bisphosphonate treatment.
    Iba K; Takada J; Hatakeyama N; Ozasa Y; Wada T; Yamashita T
    J Orthop Sci; 2008 Sep; 13(5):438-41. PubMed ID: 18843458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence based medicine and effective interventions of pharmacological therapy for the prevention of osteoporotic fractures.
    Cesareo R; Iozzino M; Alva D; Napolitano C; De Rosa B; Contini S; Mallardo L; Lauria A; Reda G; Orsini A
    Minerva Endocrinol; 2007 Dec; 32(4):275-95. PubMed ID: 18091664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New bone density conservation agents for osteoporosis under research and development: Minodronic acid].
    Takata S
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():417-20. PubMed ID: 18161142
    [No Abstract]   [Full Text] [Related]  

  • 35. [Randomized controlled trials for the prevention and treatment of glucocorticoid-induced osteoporosis].
    Suzuki Y
    Clin Calcium; 2006 Nov; 16(11):1834-42. PubMed ID: 17079850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Fluorides and bisphosphonates in the treatment of osteoporosis].
    Ringe JD
    Orthopade; 2001 Jul; 30(7):456-61. PubMed ID: 11515184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vertebral body fracture as incidental finding in thoracic radiography. Family physician usually does not learn about it].
    MMW Fortschr Med; 2003 Feb; 145(8):55. PubMed ID: 12661447
    [No Abstract]   [Full Text] [Related]  

  • 38. [Differences among bisfosfonates--specificity of risedronate (Actonel)].
    Giljević Z
    Reumatizam; 2008; 55(2):78-80. PubMed ID: 19024283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bisphosphonate therapy.
    Licata AA
    Am J Med Sci; 1997 Jan; 313(1):17-22. PubMed ID: 9001162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ranking antireabsorptive agents to prevent vertebral fractures in postmenopausal osteoporosis by mixed treatment comparison meta-analysis.
    Migliore A; Broccoli S; Massafra U; Cassol M; Frediani B
    Eur Rev Med Pharmacol Sci; 2013 Mar; 17(5):658-67. PubMed ID: 23543450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.